RA CAPITAL MANAGEMENT LLC 13D and 13G filings for Verona Pharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 6:43 pm Sale | 2024-12-31 | 13G | Verona Pharma plc VRNA | RA CAPITAL MANAGEMENT LLC | 7,777,942 8.900% | -682,148 (-8.06%) | Filing |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Verona Pharma plc VRNA | RA CAPITAL MANAGEMENT LLC | 8,460,090 9.990% | 956,114 (+12.74%) | Filing |
| 2024-02-14 5:01 pm Sale | 2023-12-31 | 13G | Verona Pharma plc VRNA | RA CAPITAL MANAGEMENT LLC | 7,503,976 9.990% | -188,014 (-2.44%) | Filing |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Verona Pharma plc VRNA | RA CAPITAL MANAGEMENT LLC | 7,691,990 9.990% | -41,086,182 (-84.23%) | Filing |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | Verona Pharma plc VRNA | RA CAPITAL MANAGEMENT LLC | 48,778,172 9.990% | 7,235,168 (+17.42%) | Filing |
| 2021-02-16 4:34 pm Purchase | 2020-12-31 | 13G | Verona Pharma plc VRNA | RA CAPITAL MANAGEMENT LLC | 41,543,004 9.990% | 41,543,004 (New Position) | Filing |